or Try an Advanced Search...

    Stage Pharmaceutical Stocks List

    Symbol Grade Name % Change
    INM B InMed Pharmaceuticals Inc. 6.38
    ITRM B Iterum Therapeutics plc 9.20
    CRNX B Crinetics Pharmaceuticals, Inc. 1.70
    CRMD C CorMedix Inc -2.79
    IKT C Inhibikase Therapeutics, Inc. -4.29
    MBRX C Moleculin Biotech, Inc. -0.13
    CASI D CASI Pharmaceuticals, Inc. -0.19
    RVPH D Reviva Pharmaceuticals Holdings, Inc. 3.91
    KPTI D Karyopharm Therapeutics Inc. -0.65
    HRMY F Harmony Biosciences Holdings, Inc. 0.79
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Cancer Disease Medicine Chemotherapy Chloroarenes Clinical Medicine Neurological Disorders Oncology Psychiatric Diagnosis Treatment Of Cancer Acromegaly Acute Myeloid Leukemia Advanced Solid Tumors Aging Associated Diseases Antibody Drug Conjugate Antineoplastic Drugs Autoimmune Disease Biotechnology Bipolar Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Stage Pharmaceutical stocks.

    Symbol Grade Name Weight
    HRTS D Tema Cardiovascular and Metabolic ETF 4.0
    MNTL D Tema Neuroscience and Mental Health ETF 3.88
    SBIO C ALPS Medical Breakthroughs ETF 2.95
    PTH D Invesco DWA Healthcare Momentum ETF 1.68
    BBP C BioShares Biotechnology Products Fund 1.67
    View all Stage Pharmaceutical ETFs...
    Compare ETFs
    Compare HRTS to BBP Compare MNTL to PTH Compare MNTL to SBIO

        Stage Pharmaceutical Stocks Recent News

        Date Stock Title
        Nov 21 ITRM Iterum Therapeutics regains full Nasdaq compliance
        Nov 21 ITRM Iterum Therapeutics Regains Full Nasdaq Compliance
        Nov 21 HRMY HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
        Nov 20 KPTI Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer
        Nov 19 RVPH RVPH: Year-End OLE Update
        Nov 18 IKT Inhibikase Therapeutics files for secondary offering of common stock
        Nov 18 KPTI Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
        Nov 17 CASI CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 RVPH Reviva Pharmaceuticals reports Q3 results
        Nov 15 CRNX Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
        Nov 15 CASI CASI Pharmaceuticals reports Q3 results
        Nov 15 CASI CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
        Nov 15 ITRM Iterum Therapeutics PLC (ITRM) Q3 2024 Earnings Call Highlights: Strategic Moves Amid Financial ...
        Nov 14 RVPH Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights
        Nov 14 CRNX UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
        Nov 14 IKT Inhibikase Therapeutics GAAP EPS of -$0.65 misses by $0.17
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Cancer Disease Medicine Chemotherapy Chloroarenes Clinical Medicine Neurological Disorders Oncology Psychiatric Diagnosis Treatment Of Cancer Acromegaly Acute Myeloid Leukemia Advanced Solid Tumors Aging Associated Diseases Antibody Drug Conjugate Antineoplastic Drugs Autoimmune Disease Biotechnology Bipolar Disorder
        Stage Pharmaceutical

        Stage Pharmaceutical is a biopharmaceutical company focused on developing innovative treatments for rare and neglected diseases. The company is developing a portfolio of novel therapies for rare and neglected diseases, including rare genetic disorders, rare cancers, and rare infectious diseases. Stage Pharmaceutical is committed to developing treatments that are safe, effective, and affordable for patients.

        Browse All Tags